Study Says That 'Micro-Walks' May Be More Effective Than Longer Ones—Even For Weight Loss
For years, doctors have stressed the importance of being active during your day—after all, research has found that sitting for too long raises your risk of a slew of serious health conditions, including cardiovascular disease and type 2 diabetes. But the idea of going for hour-long walks can be overwhelming. Now, new research suggests you don't need to jam in a massive stroll into each day: Instead, you can go for 'micro-walks.'
That's the main takeaway from a study published in Proceedings of the Royal Society B, which found that micro-walks may be even better for you than long ones. Here's the deal.
Interested in making walks part of your regular fitness routine? Check out the exclusive WH+ 4-Week Walking Plan that burns fat and builds muscle at the same time.
What are 'micro-walks'?
In this study, a 'micro-walk' is defined as walking between 10 and 30 seconds at a time (with breaks in between your next walk).
Are 'micro-walks' more beneficial for your health? Why?
It depends on how you're looking at it. In this particular study, volunteers walked on a treadmill or climbed a short flight of stairs for different periods of time, ranging from 10 seconds to four minutes. The study participants wore masks to measure their oxygen intake (which can be used to calculate energy or calorie consumption).
The researchers discovered that people who walked in short bursts used up to 60 per cent more energy than longer ones, despite the walks covering the same distance. (The more energy you expend, the more calories you can burn.)
Basically, you may be able to rev up your metabolism and burn more calories if you do short bursts of walking versus longer cruises around.
Albert Matheny, RD, CSCS, a co-founder of SoHo Strength Lab, says there's something to this. 'Getting activity throughout the day, in general, is better for people,' he says. 'It's better for circulation, mental health, and digestive health.'
You're also more likely to have a faster pace when you do shorter bursts of walking than if you're going on, say, a five-mile walk, he points out.
How many steps should I get per day?
This is debatable, and research has shown that the often-quoted 10,000 steps a day may not be necessary. Instead, 7,500 steps or so is ideal—but everyone is different.
If you've already been walking, Matheny says that aiming for 10,000 steps a day is great. But if not or if you don't have many opportunities to walk during your day, 7,500 steps may be a better goal.
'It's really about doing what you can,' he says. 'If you're not a big walker and you think, 'I don't want to walk five miles,' then just do 30-second bursts. It's more attainable.'DMX Comfort+ Sneaker
$108.49 at amazon.comGel-Nimbus 26
$109.95 at amazon.comCloudrunner 2
$240.00 at amazon.com
You Might Also Like
Jennifer Garner Swears By This Retinol Eye Cream
These New Kicks Will Help You Smash Your Cross-Training Goals
Solve the daily Crossword
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 minutes ago
- Yahoo
Eli Lilly Sinks After Obesity Pill Shows Mixed Results
The market wasn't happy with Eli Lilly's (LLY, Financials) highly anticipated weight-loss medication trial findings that recently came out. The drug, which was taken once a day, helped people lose roughly 12% of their body weight over the course of 72 weeks. That's good, but not as good as the 15% some experts had Thursday, shares fell 13% as investors took in the news. Some people said the drug would transform the game, while others couldn't get past the adverse effects. More than 10% of those on the highest dose dropped out, largely because they were sick and threw up. This is more than with other injectable GLP-1 medicines like the appeal is clear: a needle-free solution that is easy to use in a market with high demand and low supply. David Ricks, the CEO, didn't care about the selloff and said the results were "right on thesis." Lilly wants to get the drug approved by the end of the year and have it on the market by next summer at the are different opinions among doctors. Some people think it's a big step forward for people who are afraid of needles. Others say that excitement should be kept in check because it won't matter how easy it is to take if too many people are now waiting for the deeper data dive in September, which could change their minds. For now, it's a promising drug, but it's not the huge hit that bulls were hoping for. This article first appeared on GuruFocus.


Los Angeles Times
4 minutes ago
- Los Angeles Times
Generous Brands Completes Acquisition of Health-Ade
Leader in kombucha tea beverages to strengthen Generous Brands' expanding portfolio Los Angeles-based Butterfly's portfolio company Generous Brands, a leader in premium refrigerated beverages, including the Bolthouse Farms, Evolution Fresh and SAMBAZON brands, has announced that it has completed its acquisition of Health-Ade, a fast-growing leader and innovator in kombucha tea beverages, from private equity firms First Bev and Manna Tree Partners, who will also continue on as minority shareholders in Generous Brands. Since launching in spring 2024, Generous Brands has built a portfolio that spans juice, smoothie, kombucha, cold-pressed, protein, coffee and alternative soda categories. The fast-growing Health-Ade brand will complement existing portfolio brands Bolthouse Farms, Evolution Fresh and SAMBAZON beverages to create a leader in premium refrigerated beverages. The new portfolio, nearing $1 billion in retail sales, will have meaningful scale, channel strength and significant owned manufacturing capabilities, cementing its leadership position in the category. 'This is an exciting milestone for Generous Brands, bringing a leading, premium brand into our portfolio,' said Steve Cornell, CEO of Generous Brands. 'The acquisition of Health-Ade solidifies our position as a growth-oriented leader in the marketplace and reflects our commitment to meeting evolving consumer expectations. With the power of scale, we look forward to meeting more consumers with products that are at the intersection of vibrant taste and clean nutrition through transformative innovation and broader availability.' The Health-Ade brand has grown rapidly from its origins as a kombucha sold at the Brentwood Farmers Market in 2012 to become a top-selling functional beverage brand in the U.S., with retail sales approaching $250 million annually and products in 65,000 outlets nationwide. The kombucha segment has experienced consistent growth over the last five years, and Health-Ade is on track to continue growing in this expanding category. Lazard is acting as financial advisor to Health-Ade, and Baker McKenzie is acting as its legal advisor. Kirkland & Ellis advised Generous Brands and Butterfly as their legal counsel. Butterfly is a leading 'seed to fork' food ecosystem investor. Information was sourced from Businesswire. To learn more, contact pro-GenerousBrands@

Yahoo
24 minutes ago
- Yahoo
Pediatric physician addresses meningococcal vaccine
BURLINGTON, Vermont — Parents of college-bound teens have been asking pointed questions about the vaccine that more colleges are recommending to prevent meningitis in freshmen. The vaccine prevents infection from a type of bacteria called meningococcus, which can cause a life-threatening blood infection or result in meningitis, an infection of the fluid surrounding the brain and spinal cord. Meningococcus is spread by close or direct contact from the nose and throat by kissing, sharing silverware or glasses or through a cough. Studies now indicate that infants under age 1 and teens and young adults between 15-21 — especially those who will be living in close quarters with other teens such as a school dormitory — are at increased risk of getting this infection. If an infection with this bacteria does occur, one in 10 people who get it will die even with antibiotics that are designed to treat it or will experience terrible complications that can include brain damage or loss of an arm or leg. The Good News There is a meningococcal vaccine that can prevent four of the five most common strains of this bacteria or at least two-thirds to three-quarters of all cases from infecting children and, in doing so, significantly reduces the risk of their getting infected. A vaccine to treat the fifth strain is now available and a health care professional can determine the appropriate vaccine or vaccines needed and when doses should be given to protect your child or teen from meningococcal disease. Side effects of the vaccine are mild and the most common side effects are some redness or soreness at the sight of the injection and occasionally a low-grade fever. Allergic reactions have been reported but are extremely rare. Solve the daily Crossword